Announcements Trials
Browse Landscape

Status

Completed 7Recruiting 5Unknown 2Active not recruiting 2Withdrawn 1Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Kidney Failure, Chronic 1

Interventions

Drug Therapy 4Cisplatin 4Chemoradiotherapy 4lenvatinib 3camrelizumab 3Specimen Handling 3Paclitaxel 3Oxaliplatin 3Carboplatin 3toripalimab 2Surgical Procedures, Operative 2Standard of Care 2Radiotherapy 2Patient Navigation 2Methods 2Leucovorin 2Laparoscopy 2Fluorouracil 2Fluorodeoxyglucose F18 2Educational Status 2Early Intervention, Educational 2Capecitabine 2Biopsy 2Bevacizumab 2130-nm albumin-bound paclitaxel 2tislelizumab 1sintilimab 1pembrolizumab 1nimotuzumab 1irinotecan sucrosofate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Pancreatectomy × Gastrointestinal × Clear all
NCT07405099 2026-02-27

Operative Risk After Pancreatic Surgery in Patients With End Stage Renal Disease

National Taiwan University Hospital

Enrolling by invitation
100 enrolled
GastrointestinalGenitourinary

Kidney Failure, Chronic, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡